Two contrasting theories have emerged that attempt to describe T-cell ligand potency, one based on the t 1/2 of the interaction and the other based on the equilibrium affinity (K D ). Here, we have identified and studied an extensive set of T-cell receptor (TCR)-peptide-MHC (pMHC) interactions for CD4 + cells that have differential K D s and kinetics of binding. Our data indicate that ligands with a short t 1/2 can be highly stimulatory if they have fast onrates. Simple models suggest these fast kinetic ligands are stimulatory because the pMHCs bind and rebind the same TCR several times. Rebinding occurs when the TCR-pMHC on-rate outcompetes TCR-pMHC diffusion within the cell membrane, creating an aggregate t 1/2 (t a ) that can be significantly longer than a single TCRpMHC encounter. Accounting for t a , ligand potency is K D -based when ligands have fast on-rates (k on ) and t 1/2 -dependent when they have slow k on . Thus, TCR-pMHC k on allow high-affinity short t 1/2 ligands to follow a kinetic proofreading model. affinity | kinetic proofreading | MHC | rebinding | T cell receptor T cell receptors (TCRs) expressed on T cells bind host MHC proteins presenting both self-and foreign pathogen-derived peptides (pMHCs). Depending on the signal emanating from these interactions, diverse biological outcomes ensue. In the thymus, these TCR-pMHC-mediated signals shape the specificity of the mature T-cell repertoire and prevent overtly self-reactive T cells from escaping (1). In the periphery, naive T cells require continual TCR engagement with self-pMHC complexes to receive a homeostatic survival signal, whereas engagements with foreign peptides induce rapid T-cell division and the acquisition of effector functions (2). How T cells interpret the interaction between their TCR and pMHC ligands leading to these different biological outcomes is greatly debated.
Two contrasting theories have emerged that attempt to describe T-cell ligand potency, one based on the t 1/2 of the interaction and the other based on the equilibrium affinity (K D ). Here, we have identified and studied an extensive set of T-cell receptor (TCR)-peptide-MHC (pMHC) interactions for CD4 + cells that have differential K D s and kinetics of binding. Our data indicate that ligands with a short t 1/2 can be highly stimulatory if they have fast onrates. Simple models suggest these fast kinetic ligands are stimulatory because the pMHCs bind and rebind the same TCR several times. Rebinding occurs when the TCR-pMHC on-rate outcompetes TCR-pMHC diffusion within the cell membrane, creating an aggregate t 1/2 (t a ) that can be significantly longer than a single TCRpMHC encounter. Accounting for t a , ligand potency is K D -based when ligands have fast on-rates (k on ) and t 1/2 -dependent when they have slow k on . Thus, TCR-pMHC k on allow high-affinity short t 1/2 ligands to follow a kinetic proofreading model. affinity | kinetic proofreading | MHC | rebinding | T cell receptor T cell receptors (TCRs) expressed on T cells bind host MHC proteins presenting both self-and foreign pathogen-derived peptides (pMHCs). Depending on the signal emanating from these interactions, diverse biological outcomes ensue. In the thymus, these TCR-pMHC-mediated signals shape the specificity of the mature T-cell repertoire and prevent overtly self-reactive T cells from escaping (1) . In the periphery, naive T cells require continual TCR engagement with self-pMHC complexes to receive a homeostatic survival signal, whereas engagements with foreign peptides induce rapid T-cell division and the acquisition of effector functions (2) . How T cells interpret the interaction between their TCR and pMHC ligands leading to these different biological outcomes is greatly debated.
Two competing models of T-cell activation have been proposed, with ligand potency being a function of TCR-pMHC equilibrium affinity (K D ) (3-7) or t 1/2 (8) (9) (10) (11) . Evidence supporting K D -based receptor occupancy models of TCR signaling comes from sets of ligands that show a correlation between the K D and ligand potency (3, 5) and from the fact that ligands induce qualitatively distinct biological outcomes depending on their concentration (12) .
In sharp contrast to receptor occupancy models, t 1/2 -based kinetic proofreading models hypothesize that the TCR must be engaged long enough to complete a series of signaling events, including coreceptor recruitment and TCR phosphorylation (13) . Increases in the t 1/2 of the TCR-pMHC engagement raise the probability that any single TCR-pMHC engagement will surpass the threshold amount of time required to initiate T-cell activation (14) . Recently, this threshold amount of time has been predicted to be at least 2 s (9, 15) . Whether there is, in addition, an optimal t 1/2 that balances these kinetic proofreading requirements and the serial triggering of TCRs has been debated (16, 17) .
Further evidence supporting t 1/2 -based kinetic proofreading models arises from the discovery of antagonist pMHC ligands (18) . TCR antagonists induce partial but not complete phosphorylation of the TCR complex and fail to activate T cells fully at any ligand concentration (18) . The subsequent discovery that antagonist ligands bind TCRs with a shorter t 1/2 than stimulatory agonist-pMHC complexes further suggests that activating ligands must engage a specific TCR for a long enough period to allow a series of signaling events to occur (19, 20) .
As compelling as the arguments are for t 1/2 models of T-cell activation, discoveries of highly potent T-cell ligands with a short t 1/2 suggest that T-cell activation may not be solely dependent on the dwell time (4-6, 21, 22) . In an attempt to reconcile why neither K D nor t 1/2 fully predicts ligand potency, we have identified low-, medium-, and high-potency T-cell ligands that have medium and fast binding kinetics. The potency of these ligands fails to be described by either a K D or t 1/2 -based model. By mathematically modeling the biophysical mechanisms leading to T-cell activation using standard assumptions, our results indicate that fast k on allow an individual TCR to bind and rebind rapidly to the same pMHC several times before diffusing away. The rebindings lead to an aggregate t 1/2 (t a ) that can be significantly longer than individual TCR-pMHC interactions. Importantly, ligand potency correlates closely with this t a regardless of whether the ligands have fast or slow k on or t 1/2 s. These findings demonstrate that K D and t 1/2 models of T-cell activation are not mutually exclusive, because both emerge from a t a model. In particular, the t a depends on the t 1/2 or K D alone when k on are low or high, respectively. The t a allows strong K D /fastbinding kinetic ligands to follow a kinetic proofreading model of activation.
Results
Identification of High, Medium, and Low K D TCR-pMHC Interactions with Fast Rates of Association and Disassociation. During our previous study of TCRs specific for IA b /3K, we noticed that several of these TCRs bound IA b /3K with a strong K D using very fast binding kinetics (22, 23). However, because some of the k off were exceptionally fast, with loss of all specific binding for some occurring in less than 1 s, the original measurement had a significant error range. Using surface plasmon resonance (SPR) focusing on obtaining TCR-pMHC disassociation rates, we measured the binding kinetics of the B3K506 and B3K508 TCRs interacting with the previously reported and additional IA b /3K altered peptide ligands (APLs) (Fig. 1) .
Although the B3K506 and B3K508 TCRs interact with the IA b /3K complex with a conventional K D for agonist ligands (7 μM for the B3K506 and 29 μM for the B3K508), the binding kinetics of the interaction of the B3K506 TCR with IA b /3K are extremely fast: k on = 101,918/M·s and k off = 0.7/s, leading to a t 1/2 of 0.9 s (Fig. S1 and Table S1 ). (Fig. 2) . Because the peptides with a K D or t 1/2 beyond the SPR detection limit failed to induce significant activation, we do not consider them in our subsequent analysis. Of critical importance, except for a 2-fold increase in binding by the 3K P2A peptide to IA b , the peptides all bind similarly to IA b proteins (24). Furthermore, mature B3K506 and B3K508 CD4 T cells are equally sensitive to anti-CD3-mediated T-cell signaling, suggesting that the responses of these different T cells to stimulatory ligands can be directly compared (Fig. S2 ). Our data confirm that fast kinetic ligands can signal, suggesting that the 2-s limit on t 1/2 is not absolute. Notably, the B3K506 undergoes proliferation at submicromolar peptide concentrations by the 3K, P5R, P8R, and P-1A ligands (t 1/2 = 0.9, 0.9, 0.8, and 0.3 s, respectively) (Table S1) .
Some T-cell ligands with a shorter t 1/2 than the immunizing ligand can induce superagonist or partial T-cell effector functions if the TCR complex is not efficiently ubiquitinated (18, 25) .
To determine whether B3K506 and B3K508 T cells undergo complete activation in response to fast kinetic ligands, we chose two additional cellular functions to explore: (i) ligand-induced TCR down-regulation as a measure of receptor phosphorylation, ubiquitination, and degradation by Cbl-b (26) and (ii) cytokine production by T cells. Consistent with inducing complete phosphorylation of the TCR complex and T-cell activation, fast kinetic ligands induce TCR down-regulation and TNF-α production ( Fig. S3 and Table S1 ). Model. Individually, ligand potency for the B3K506 or B3K508 T cells loosely follows the overall trend of both K D -and t 1/2 -based models. However, when B3K506 and B3K508 T-cell activation data are compared, neither model suffices ( Fig. 3 and Table S1 ). In regard to K D , the B3K508 T cells are hyperresponsive. For example, the 3K ligand induces proliferation of B3K506 and B3K508 T cells at a similar nanomolar range concentration, despite having significantly different K D s (7 vs. 29 μM). In another example, the B3K506 TCR binds IA b /P-1A (26 μM) with a similar K D as the B3K508 TCR binding IA b /3K (29 μM), yet the B3K506 T cells proliferate at an EC 50 that is 23-fold less than that of the B3K508 T cells. A failure of K D to define the ligand potency is further apparent when additional 3K APLs are tested (Fig. 3A and Table S1 ).
In reverse correlation from K D , ligand potency does not correlate with t 1/2 because the B3K506 T cells are hyperresponsive. 3K  P5R  P2A  P5A  P-1A   3K  P5R  P8R  P-1A  P8A  P-1K  P8Q  P 1L 1,000 The 3K ligand induces similar proliferation of the B3K506 T cells (t 1/2 = 0.9 s) as the B3K508 T cells (t 1/2 = 2.2 s) ( Table S1 ). In addition, the P5R ligand is significantly less potent in activating the B3K508 T cells than the 3K ligand is in activating the B3K506 T cells, despite having a similar t 1/2 (0.7 and 0.9 s, respectively). Multiple discrepancies can be observed when comparing other 3K APLs ( Fig. 3B and Table S1 ). The finding that each T cell in isolation loosely follows both K D -and t 1/2 -based models appears to be an artifact of limited variation in the kinetics among the ligands for each T cell. A failure of K D or t 1/2 to predict ligand potency is true for cytokine production as well, suggesting that the proliferation response is not anomalous (Fig.  S3 and Table S1 ). Consistently, activating ligands for B3K506 T cells use a fast k on or strong K D to compensate for a short t 1/2 . (Because there is a simple relation among them, only two of the three parameters describing the interaction are independent.) Vice versa, B3K508 T cells compensate for a weak K D by engaging IA b /3K ligands for a longer t 1/2 . These results suggest that ligand potency is determined by an interplay between the TCR-pMHC k on and t 1/2 (or K D and t 1/2 ) in a way that allows for enhanced signaling by fast kinetic ligands. In an attempt to reconcile how the interplay of K D and binding kinetics influences T-cell activation, we evaluated whether straightforward merging of the two predicts ligand potency. A combined K D and t 1/2 model suggests that increasing the frequency or total number of TCRs engaged by pMHCs would stochastically result in an increase in the number of uncharacteristically long TCR-pMHC interactions. To test this, we identified the change in receptor occupancy required for a strong K D fast kinetic ligand to be bound to an equal number of TCRs, on average, for at least 2 s as compared with a medium kinetic medium K D ligand.
To approximate how frequently each pMHC ligand is bound to a TCR, we assume that a quasiequilibrium between TCRs and pMHCs occurs on the time scale of cell-cell contact and that TCRs are far in excess of the relevant pMHCs. The probability that a pMHC is bound to a TCR then depends on the equilibrium association affinity (K A ) through a simple saturation curve (3):
The parameter c higher (80-430 per square micrometer) (27); however, increasing this value had little effect on our results. To convert the measured K A of the TCR-pMHC pair in solution to K A when the TCRs and pMHCs are membrane-bound, we have used a confinement length measured for the 2B4 TCR interacting with the MCC88-103 ligand (1.2 nm, corresponding to a conversion factor of 0.262 nm) (8) .
The TCR-pMHC saturation curve from Eq. 1 contains a threshold K D , K*, above which pMHC ligands are bound at least 50% of the time. Using the above approximations, K* is 130 μM and pMHC ligands with a 43-μM K D are bound 75% of the time (Fig. 4) . These values mirror measurements made by Grakoui et al. (8) , in which the majority of a 60-μM K D pMHC ligand was bound to a TCR when located within the interface of T cells and APCs. As a result of ligand saturation, strengthening K D above 100 μM has only a modest effect on the overall frequency of TCRs bound to pMHCs. This saturation curve can be used to show that changes in TCR-pMHC occupancy do not describe ligand potency (SI Text).
By comparing ligands with similar EC 50 s of proliferation yet different t 1/2 s, we tested whether a merged K D /t 1/2 model describes ligand potency. Specifically, the tests evaluate whether a stronger K D for the B3K506 TCR engaging the pMHC generates enough additional bindings to overcome the lower probability of the bindings being long-lived. One comparison is the B3K506 TCR interacting with 3K/P-1A peptide (K D = 26 μM, t 1/2 = 0.3 s, EC 50 = 9 nM) and the B3K508 TCR interacting with the 3K/P5R peptide (K D = 93 μM, t 1/2 = 0.7 s, EC 50 = 15 nM). Assuming that TCRs bind pMHCs with exponentially distributed dwell times, the B3K506 TCR would have to bind 26-fold more IA b /P-1A ligand than the B3K508 TCR binding IA b /P5R to generate an equal number of 2-s engagements. However, the 3.6-fold difference in K D between the two TCR-pMHC pairs leads to only a 1.5-fold difference in receptor occupancy. The effect is qualitatively similar for other comparisons (Fig. S4A ) and is largely robust to assumptions about the parameters (SI Text). Thus, a merged K D /t 1/2 model does not properly account for ligand potency. Based on similar reasoning, the effects of serial triggering cannot contribute significantly to ligand potency ( Fig. S4 B and C and SI Text). It appears that the roles of the k on and K D in our data are not to increase the number of bindings, either at any given time (receptor occupancy) or over time (serial triggering).
Could Rebinding of TCRs to pMHCs Expand the Dwell Time for Fast
Kinetic Ligands? The failure of K D , t 1/2 , or serial triggering models indicates that other mechanisms must underlie ligand potency. The hypothesis of serial triggering, that individual pMHCs can sequentially bind multiple TCRs, led us to wonder whether a pMHC can bind multiple times to the same TCR. The ability of a receptor/ligand pair to associate, disassociate, and reassociate in a finite amount of time before complete disengagement is termed "rebinding." Although TCR-pMHC interactions are usually thought of as single binding events, it is theoretically possible that ligands with fast k on may be able to rebind TCRs (28), especially because they are bound on membranes on which diffusivities are typically slower than in solution. If it occurred, TCR-pMHC rebinding would generate an aggregate dwell time (t a ) of interaction, assuming that the rebindings occur faster than the TCR signaling complex disassembles.
To investigate whether TCR-pMHC rebindings are plausible, we have followed an extensive set of work analyzing diffusioninfluenced reactions (29, 30). Our approach has been to apply the particular estimate of the t a , including rebindings, as provided by Bell (31), because of its simplicity and to suggest that the qualitative results are robust to the choice of model (see below and SI Text). In applying Bell's model (31), we assume that pMHCs and TCRs move purely diffusively on flat stiff membranes. Neglecting membrane forces is potentially in conflict with emerging work indicating the role of the actin cytoskeleton in breaking TCR-pMHC bonds, decreasing their t 1/2 (32). However, when k on are fast enough for rebinding to occur, they happen very quickly; thus, it is unclear how much membrane forces could intervene.
The model also assumes that all rebindings occur at the same rate, which neglects any stabilization of binding that may be provided by coreceptors. Stabilization would have the effect of increasing the propensity of rebinding. Furthermore, the model counts only those rebindings that occur almost immediately, before the TCR and pMHC separate by more than a molecular length scale (e.g., 100 Å), on the order of 1 ms using the parameters below. Although the molecular details of TCR activation are not entirely understood (33, 34), TCR activation is not expected to be appreciably reversed on such short time scales.
Within this framework, Bell's result (31) for the total dwell time, summing the duration of any rebindings that occur, is:
The parameters D TCR and D pMHC represent the diffusivities of TCR and pMHC, respectively. From Bell's result (31), it can be seen that the t a is dependent on the individual t 1/2 and K D . The first term in Eq. 2 accounts for the duration of the first binding, whereas the second affinity-dependent term accounts for any subsequent rebindings. Noting that every individual binding event lasts, on average, as long as any other, the expected number of rebindings between a particular pMHC-TCR pair is:
The parameter k on denotes the on-rate of the pair on the membrane. The system has qualitatively different dependence on t 1/2 and K D when k on are small and large. When k on are fast relative to the diffusion rates, pMHC binds and rebinds the same TCR many times, reaching a quasiequilibrium before diffusing away. As a result, the K D dominates the duration of the interaction when k on are high. However, when k on are slow, rebinding does not occur and t 1/2 dominates. Because Eq. 2 can be independently motivated by simple arguments such as these, it is qualitatively robust to the choice of model (SI Text).
More generally, Eq. 3 suggests that there is a threshold k on above which rebindings are relevant:
Whenever the k on exceeds this threshold (Eq. 4; also known as the diffusion-limited rate), at least one rebinding is expected to occur. Importantly, the specific parameter values are important only insofar as they influence this threshold and not the underlying biophysical event (Figs. S5 and S6).
Rebinding of TCRs to pMHCs Uniquely Explains How Fast Kinetic
Ligands Induce T-Cell Activation. To evaluate whether rebinding could have an impact on the dwell time of B3K506 or B3K508 TCRs engaging pMHC ligands, we applied Eq. 2 to our dataset. The diffusivities for a TCR and pMHC were estimated at 0.04 and 0.02 μm 2 /s, respectively, corresponding to midrange measured values (SI Text). On-rates measured using SPR were converted to k on on the membrane by assuming (i) that k off of membrane-bound TCRs binding pMHCs are identical to SPR measurements and (ii) that the K D s of membrane-bound TCRs engaging pMHCs are proportional to SPR-measured affinities, as done in our analysis of receptor occupancy. Because of limited data, it is generally difficult to convert SPR-measured k on directly to k on on the membrane (35, 36). We discuss sensitivity to the assumptions in SI Text.
Using these parameter values, rebinding likely occurs for TCR-pMHC pairs with fast binding kinetics (Fig. 5) . Specifically, this initial model predicts that the threshold on-rate for rebinding is 60,000/M·s. As a result, the expected number of rebindings increases from almost none to 1.7 as the on-rate increases in our sample from 11,000/M·s to 102,000/M·s. Because T-cell activity is generally thought to be very sensitive to t 1/2 , a factor of 2 or 3 can be important. When rebindings are accounted for, the highly potent B3K506 T-cell ligands 3K, P5R, and P8R change from a t 1/2 of 0.9 or 0.8 s to t a s of 2.7, 1.9, and 1.8 s and the medium potent P-1A ligand converts from a t 1/2 of 0.27 s to a t a of 0.72 s. Importantly, the t a is significantly better at predicting ligand potency than the K D or t 1/2 ( Fig. 6C and Figs. S4, S7, and S8).
Within the dataset, two groups of high-or medium-potency ligands arise from different TCR-pMHC binding parameters (Table S1 ). Using these groups, the competing models can be quantitatively evaluated. The four high-potency ligands (3K, P5R, and P8R binding the B3K506 TCR and 3K binding the B3K508 TCR) have K D s and t 1/2 s that vary widely by factors of 4.0 and 2.7, but t a s that vary only by a factor of 1.5 (Fig. 6C) . The two ligands in the second most potent group (B3K506 TCR binding P2A and B3K508 TCR binding P5R) have K D s and t 1/2 s that vary by factors of 3.6 and 2.6, respectively, but t a s that are almost identical, varying only by a factor of 1.1.
Although our t a model was generated without empirically fitting the data, our estimate for the rebinding threshold, 60,000/ M·s, is near the best fit for minimizing the variation in the t a s of the most potent group of ligands (Fig. S5) . Quite similarly, for the medium-potent ligands, the best-fit threshold is 45,000/M·s (Fig. 6D) . Convergence of the t a model with empirical data suggests that the assumptions and underlying biophysical process are correct.
Discussion
Binding of two proteins is governed by the K D , k on , and t 1/2 , any two of which suffice to describe the interaction because the three are simply related. Although ligand potency could be dependent on each of these binding characteristics, research over the past two decades has suggested that only the K D or t 1/2 matters. Mechanistically, these two mutually exclusive models have been interpreted to mean that T cells are either (i) sensitive to the number of TCRs simultaneously bound to pMHC (3) (4) (5) (6) or (ii) sensitive to ligands that produce a long enough interaction to phosphorylate the TCR complex fully (8-11, 13). In seeming contradiction to both theories, data presented here suggest that neither the K D nor t 1/2 determines the potency of T-cell ligands.
A plethora of data suggests that T cells are increasingly sensitive to long-lived TCR-pMHC engagements, with a t 1/2 of 2 s being near the shortest allowable time (9, 15) . Additionally, T-cell responses are dependent on ligand concentration, suggesting that T cells are also responsive to the frequency of these long-lived bonds. With this as a starting point, we asked how changes in the k on or K D might allow T cells to be equally reactive to ligands with a different t 1/2 . The IA b /3K model system is particularly well suited for this analysis because each of the 3K APLs binds IA b similarly and a relatively large number of TCR-IA b /3K APL pairs contain several that have similar potency, although using different K D s and binding kinetics. These controlled combinations of T cells and pMHC ligands allowed a direct comparison of the different theories of T-cell activation.
Because high-potency T-cell ligands with short t 1/2 s all have fast k on , we hypothesized that TCR-pMHC interactions may be influenced by diffusion rates. Although rebinding is potentially relevant for any binding event, it will be less important for cytosolic reactions because diffusivities in the cytoplasm are relatively high (31). However, when both the receptor and ligand are anchored on membranes, the rates of diffusion are drastically reduced. A recent study of the interaction between membranebound CD2 and CD58 using fluorescence recovery after photobleaching (FRAP) suggests that the fast-binding pair may rebind 100 times before separating, significantly increasing the duration of the bonds (37) and potentially explaining the pair's physiological activity (38).
Modeling TCR-pMHC interactions when both are membrane-bound shows that fast k on allow rebinding to occur.
Depending on the k on , this effect can greatly extend bond durations, allowing medium-potency ligands with measured t 1/2 s of 0.3 and 0.7 s to generate a t a near 1 s. As an independent example, the lymphocytic choriomeningitis virus-specific P14 TCR has been shown to bind its cognate H-2D b -gp33 ligand with a low t 1/2 of 0.7 s (21). Because of a fast k on of 400,000/M·s, our rebinding model predicts that the P14 TCR would have a t a of 5.5 s, which is fully consistent with kinetic proofreading models of activation.
Most importantly, a rebinding-mediated t a uniquely predicts ligand potency for B3K506 and B3K508 T cells (Fig. 6) . Although our data initially appear to be in conflict with both K Dand t 1/2 -based activation models, the t a model is consistent with reports that either t 1/2 or K D can be the better predictor of ligand potency. T-cell ligands with slow k on are predicted to follow a strict t 1/2 -based reactivity pattern because rebinding does not occur and the t a is equal to the t 1/2 of a single binding event. The canonical t 1/2 -dependent systems, such as the 2B4-IE k /MCC and 3L.2-IE k /Hb TCR-pMHC pairs, have slow k on compared with the rebinding threshold we have estimated (45,000-60,000/ M·s) (10, 11) . Because most T-cell activation studies have been done using these systems, t 1/2 -based models have appeared sufficient and rebindings have not been required to understand ligand potency. For example, the k on for the t 1/2 -dependent 2B4/MCC system studied by Krogsgaard et al. (10) are all less than 6,670/M·s, such that almost no rebindings (<0.15) are predicted to occur.
In contrast to the canonical t 1/2 models, most T-cell activation studies suggesting that K D is a better predictor of ligand potency have k on larger than or close to the rebinding threshold (5, 6) . Our data suggest that these correlations with K D occur because 
, with the more potent peptide having a 14-fold faster k on and a predicted 1.3-to 1.4-fold longer t a according to our model. Thus, observations that ligand potency is dependent on K D or t 1/2 are not in conflict with each other; rather, they are different manifestations of the interaction between the T cell and APC when the k on is very fast or very slow. With the continuing emergence of T-cell ligands with very fast k on (4), our findings are likely to have an impact on a large repertoire of T cells.
On completion of this work, we have become aware of results for CD8 + T cells that are in harmony with our conclusions (39). b /3K peptide variants were expressed and produced using the baculovirus expression system, as previously described (1, 2). K D s and binding kinetics for TCRs binding to IA b /3K and APLs were obtained on BIAcore 2000 and 3000 instruments (BIAcore AB). Data points were collected at 0.2-s intervals and analyzed with Bioeval 4.1 software (BIAcore AB). Scatchard analyses of the equilibrium data were used to determine the dissociation constant (K D ). The kinetic data were used to determine the dissociation rate (k off ) and the association rate (k on ) were calculated from the K D and k off (k on = k off /K D ).
Materials and Methods
C57BL/6 mice were purchased from the Jackson Laboratory. Rag1 −/
Tests of Different Models of Ligand Potency and Sensitivity to Model
Parameters. Tests to determine whether T-ligand potency correlates with TCR-pMHC occupancy when TCRs and pMHCs are membrane-bound. Tcell ligand potency does not correlate with the measured K D (Fig.  3A) . Even though the K D measurement of soluble proteins does not describe ligand activity, it is possible that changes in receptor occupancy when TCRs and pMHCs are membrane-bound do describe our data. In this section, we provide an alternate argument against receptor-occupancy (K D )-based theories. In the main text, we concluded that the affect of K D on receptor occupancy is weak because of saturation effects (Fig. 4) . Thus, for a K D -based model to explain the wide range of activities seen in our dataset, the effect of receptor occupancy on activity would have to be quite strong.
To assess directly whether changes in receptor occupancy can account for ligand potency, we have compared two quantities: (i) the dose-response of a T cell to different concentrations of ligand and (ii) the response of the T cell, at fixed concentrations of ligand, to ligands with different K D s. Because changes in concentration and K D lead independently to changes in receptor occupancy, the dose-response curves and the mutation studies provide independent measures of the effect of receptor occupancy on activity. By comparing K D -based changes in receptor occupancy (comparing different ligands) with concentrationbased changes (comparing the same ligand at different concentrations), the impact of K D can be directly assessed. To do so, we posited that changes in peptide concentration lead directly to changes in receptor occupancy, assuming that TCRs are in great excess and that the additional peptide binds MHC. For example, we assume that a 2-fold increase in peptide concentration leads to a 2-fold increase in pMHC-TCR engagement.
Consonant with our arguments against a pure K D theory in the main text, the data indicate that the effect of receptor occupancy on activity is not strong enough to explain our data. The doseresponse curves indicate that large changes in receptor occupancy are required to increase activity, which are far larger than the difference in receptor occupancies between two peptides with different K D s. This can particularly be seen by examining the responses of the B3K506 TCR to two different peptides, IA b /3K and IA b /P-1A. The IA b /3K peptide is more stimulatory for the B3K506 TCR than for the IA b /P-1A peptide at every concentration of peptide. In particular, at a concentration of 0.0001 μM, the 3K peptide induces 14-fold more proliferation than the P-1A peptide. The 3K peptide also has a stronger K D (7 and 26 μM, respectively), in apparent agreement with a K D theory. Its 4-fold higher affinity can lead at most, however, to a 4-fold higher receptor occupancy at each concentration of peptide (Eq. 1). Because of saturation, the actual increase is probably less. In fact, using estimates of relevant parameters, we predicted in the main text that its receptor occupancy is only 12% higher than the receptor occupancy of the P-1A peptide (Fig. 4) .
For the K D model to explain the differential activity of these two peptides, a 4-fold increase in receptor occupancy must be able to generate a 14-fold increase in proliferation. A 4-fold increase in the concentration of P-1A from 0.0001 μM, however, barely increases its proliferation (2-fold). In fact, the concentration of the P-1A ligand must be increased over 50-fold to recapitulate the activity of the 3K peptide at 0.0001 μM. Even if a 50-fold increase in concentration leads to a smaller increase in receptor occupancy, the gap is quite large.
Because the different affinities in our dataset lead to only small differences in receptor occupancy and peptide activity is not very sensitive to receptor occupancy, K D theories do not explain our data. Testing the impact of serial triggering. Because neither K D nor t 1/2 models, independently or combined, explained the T-cell activation data, we assessed whether serial triggering could influence ligand potency. The serial triggering hypothesis postulates that an individual pMHC can sequentially trigger multiple distinct TCRs (3, 4) . Thus, the faster on-rate of IA b /3K-binding B3K506 TCRs would lead to a greater number of distinct binding events over the course of the T-cell-APC interaction. Serial triggering of many more TCRs by fast kinetic ligands vs. slow kinetic ligands could lead to an increase in the probability of generating uncharacteristically long-lived interactions.
To test whether serial triggering accounts for the ligand potency of IA b /3K-reactive T cells, we determined how many more binding events would be required for a strong K D and fast kinetic ligand to bind an equal number of TCRs for at least 2 s as a medium kinetic and medium K D ligand. We followed the analysis conducted by Coombs et al. (5) . In this model, the number of distinct TCRs bound by a pMHC is as follows:
The parameter T denotes the total time a pMHC is present in the APC-TCR interface. Because the number of distinct TCRs a pMHC binds depends on the affinity and k on in exactly the same way as the receptor occupancy, the conclusion that serial triggering also does not account for our data is not surprising.
As an example, we compared the responses of the fast kinetic B3K506 TCR binding the IA b /P-1A ligand and the B3K508 TCR binding IA b /P5R. These two peptides induce similar activity but have different K D and binding kinetics. If we assume that TCRs binding pMHC have exponentially distributed dwell times, as in the main text, then to have a similar probability of engaging pMHC for 2 s, the B3K506 TCR would have to generate 26-fold more distinct binding events to the IA b /P-1A ligand than the B3K508 TCR binding IA b /P5R. However, the 3.6-fold difference in K D between the two TCR-pMHC pairs leads to only a 6.5-fold difference in the in number of distinct bound TCRs. The impact of serial triggering on equalizing t 1/2 s becomes worse when a higher t 1/2 threshold is assumed (Fig. S4C) , further suggesting that serial triggering cannot lead to significant increases in uncharacteristically long-lived TCR-pMHC interactions. Most importantly, both the B3K506 and B3K508 T cells demonstrate enhanced activity to ligands with increasing t 1/2 . These data indicate that for fast kinetic medium and strong K D ligands, T-cell activation is negatively correlated with increasing numbers of binding events.
Model and parameter sensitivity analysis. A. Model merging receptor occupancy and dwell time. In the main text, we estimated parameters in Eq. 1 to evaluate whether receptor occupancy and dwell time models could jointly explain our data. Recent arguments suggest that the relevant TCR concentration in Eq. 1 is the effective concentration of TCRs in the synapse, averaged over TCR-rich and TCR-sparse regions, assuming that the TCRs can move freely between the two regions (6) . Thus, the concentration of TCRs in the interface between the T cell and APC, c 0 TCR , was estimated in the main text by dividing the total number of TCRs on a T cell (10,000 TCRs per T cell) by the total surface area of a T cell (500 μm 2 ), leading to an estimate of 20 TCRs per square micrometer (7) . Within TCR-rich regions (e.g., islands), c 0 TCR is locally much higher (80-430 TCRs per square micrometer) (8). Although we have used the lower effective concentration of TCRs, higher concentrations would only improve the robustness of our conclusions, as we demonstrate below.
To convert the measured K A of TCR-pMHC in solution to K A when the TCR and pMHC are membrane-bound, we have used a confinement length measured for the 2B4 TCR interacting with the MCC88-103 ligand (1.2 nm, corresponding to a conversion factor of 0.262 nm) (7) . Although this conversion has precedent, it is uncertain, as recent research reveals (9, 10). The need for more direct measurements of membrane kinetics has long been acknowledged (11) . In particular, one recent study of pMHC-TCR kinetics on the membrane has suggested that k on and k off are faster on the membrane than solution-based measurements suggest and that actin-cytoskeleton-driven membrane motion has a role in tearing apart bonds (10) . The role of the membrane in breaking apart bonds as short-lived as those in this study is unclear.
Because the parameters involved in our models are uncertain, we checked to determine if our conclusions were robust to parameter variations. First, we checked the validity of our conclusion that the receptor occupancy is saturated. To do so, we varied the K*, modeling uncertainty both in the concentration of TCRs on the T cell and in likely errors in converting SPRmeasured affinities to affinities on the membrane (Fig. S6) . If the threshold K D is weaker than our estimate, even weakly binding peptides will almost always be bound and the conclusion is robust. As the threshold K D becomes much stronger than our estimate, some of the weaker binding peptides in our sample become unsaturated. Even in these cases, however, it is unlikely that changes in the K D could compensate for changes in the t 1/2 in a merged receptor occupancy/dwell time model. The dwell time depends strongly (exponentially) on the t 1/2 , whereas the receptor occupancy depends weakly (sublinearly) on the K D , even if the system is not saturated (see the arguments in the tests of the pure affinity model).
B. Rebinding. B1. Model sensitivity. In the main text, we applied Bell's model (12) to estimate the importance of rebinding on the membrane. Here, we briefly motivate rebinding models to suggest that our qualitative conclusions are robust to the choice of model.
Once a ligand and receptor debind, we assume that there is some probability they will rebind within a given time interval. Suppose we knew this probability (p). The number of rebindings would then be a geometrically distributed random variable with parameter 1−p, assuming that every rebinding is independent, and the expected number of rebindings would be p/ (1−p) .
What is the probability p? Clearly, it depends on the time interval over which rebindings are counted. In the case of the interaction between TCRs and pMHCs, we are only interested in those rebindings that occur relatively quickly, before the TCR signaling complex disassembles. Because it is unclear how quickly the TCR signaling complex disassembles, however, models must choose a different measure of "quickness." (Analytically, other measures are also more tractable.) One reasonable approach is to count only those rebindings that occur before the pMHC binds to another TCR for the first time.
In a different approach, Bell's model (12) can be interpreted to count only those rebindings that occur almost immediately, before the receptor and ligand are ever separated by more than a molecular distance. To see this, consider the probability that a pMHC binds to a TCR before diffusing away when it is within a molecular distance of the TCR. For simplicity, we can model the reaction and diffusion as competing exponential processes with rates corresponding to their characteristic rates, which scale as k on /L 2 and D/L 2 , respectively, where L is the molecular distance. (Note that k on is expressed on a per molecule basis.) Applying this simple analysis to determine the probability p (13), it is possible to obtain Bell's model (12) (Eq. 2), within a constant factor.
How sensitive are the conclusions to the particular choice of model? Clearly, the choice of which rebindings to count will affect the quantitative results. Allowing more time for the pMHC and TCR pair to rebind, for example, will lead to larger predictions for the t a . The qualitative prediction of the model, however, is robust. Independent of the choice of model, the t a will depend on the t 1/2 and K D when k on are low or high, respectively, and on a combination of the two when k on are intermediate. The robustness of this conclusion stems from the fact that it can be motivated independently by simple arguments. When k on are slow, rebinding will not occur and the t a will depend on the single-interaction t 1/2 . Conversely, when k on are fast, a pMHC and a TCR will rebind many times, essentially equilibrating. As a result, the t a will depend only on the K D when k on are large.
B2. Parameter estimates and sensitivity. To evaluate whether rebinding could have an impact on the dwell time of B3K506 or B3K508 TCRs engaging IA b /3K and APL ligands, we estimated the parameters in Eq. 2. The diffusivity for a TCR and a pMHC was estimated using published experimental measurements. We used 0.04 and 0.02 μm 2 /s as typical estimates of the diffusivities of a pMHC (14-16) and a TCR, respectively (17) (18) (19) . The range of reported diffusivities is from 0.01 to 0.1 μm of k on to k on on the membrane by assuming that affinities on the membrane are proportional to SPR-measured affinities, as in our analysis of receptor occupancy, and, further, by assuming that k off on the membrane are identical to those measured by SPR. Because of limited data, it is generally difficult to convert SPRmeasured k on to k on on the membrane (11, 20) . A recent study of pMHC-TCR kinetics on the membrane has suggested that k on and k off are faster on the membrane than solution-based measurements suggest and that actin-cytoskeleton-driven membrane motion has a role in tearing apart bonds (10) . The role of the membrane in breaking apart bonds as short-lived as those in this study is unclear. Additionally, because faster k on promote rebinding but membrane motion driving the pair apart inhibits rebinding, it is too early to understand how our qualitative results would be affected.
Because of the uncertainty in these parameters, we checked the robustness of our conclusion that rebinding explains the potency of the peptides in our dataset. To do so, we varied the threshold for rebinding, k on *, which models uncertainties in the diffusivities of the TCR and the pMHC and errors in converting SPR-measured k on to k on on the membrane. It is also a rough way of accounting for other factors that might increase or decrease the likelihood of rebinding, such as membrane motion, as well as uncertainty in the model itself. Threefold differences in the threshold k on do not qualitatively affect our conclusions (Figs. S5 and S7). As the threshold for rebinding increases, rebindings become less likely for any given pMHC-TCR pair and the effect of rebinding on the t a weakens. As long as the rebinding threshold falls within or near the range of k on in our data, it will explain at least part of the difference between the B3K506 and B3K508 TCRs, balancing their K D and t 1/2 .
Independent of the parameter estimates, we also provided bestfit values in the main text, which, being close to our estimates, reinforced our conclusions. We provide another type of best-fit analysis, based on fitting the models to groups of peptides with similar activity, in Fig. S8 to show this conclusion in another way. 
B. C. D. (4, 8, 16 , and 32 μM) (A), P5R (5.6, 11.2, 22.5, and 45 μM) (B), P8R (8, 16, 32 , and 64 μM) (C), P-1A (8, 16, 32 , and 64 μM) (D), P8A (8, 16, 32 , and 64 μM) (E), P-1K (12.9, 25.7, and 51.4 μM) (F), P8Q (13, 26, and 52 μM) (G), P-1L (16, 32, and 64 μM) (H), P8L (4, 8, 16 , and 32 μM) (I), and P2A (4, 8, 16 , and 32 μM) (J). No specific binding was detected for the P3A, P5A, and P5Q ligands interacting with the B3K506 TCR. For the B3K508 T cells, soluble IA b /3K or variant peptides were injected at 20 mL/min for 60 s through a CM5 biosensor flow cell at a concentration of 3K WT (4, 8, 16 , and 32 μM) (K), P5R (5.6, 11.2, 22.5, and 45 μM) (L), and P2A (4, 8, 16 , and 32 μM) (M). Limited binding was detected for the P5A ligand binding the B3K508 TCR at 32 and 64 μM. No specific binding was detected for the P-1A, P8R, P8A, and P3A ligands interacting with the B3K508 TCR. As a control for bulk fluid phase refractive index, the IA b -3K preparations were also injected through a fourth flow cell with an immobilized irrelevant TCR Ani 2.3 specific for HLA-DR52c. All samples reached equilibrium binding within 10 s. The complex was allowed to dissociate for 60 s between injections. Raw data were corrected for the bulk signal from buffer and IA b -3K by performing identical injections through a flow cell in which an irrelevant TCR was immobilized. The data were further corrected for the loss of captured TCR during the series of injections based on the observed k off of the TCR from the anti-Cα mAb (∼4. The pMHC-TCR pairs are ranked according to the average number of interactions between them, at any given time, that have lasted longer than 2 s This average number was calculated as the product of two quantities: (i) the fraction of peptides bound at any given time, as given in Eq. 1, and (ii) the fraction of such bindings that lasts longer than 2 s, assuming exponentially distributed binding times. The result has been normalized by the B3K508 peptide interacting with the 3K peptide, which is predicted to be the most active. The results are fairly insensitive to the parameter estimates because of the strong (exponential) dependence on the t 1/2 and the weak (sublinear) dependence on the affinity. (B and C) Model merging serial triggering and dwell time does not explain the activities of the pMHC-TCR pairs. The pMHC-TCR pairs are ranked according to the number of distinct interactions between them that last longer than a threshold time. The number of interactions is normalized by the number of interactions for the B3K506 TCR interacting with the 3K peptide, which is predicted to be most active. The threshold time required to activate a TCR is assumed to be 2 s (B) and 34 s (C). (C) Note that this panel is on a log scale. Fig. S5 . Determining the optimal rebinding threshold for the data. The variation in t a s within groups of similar activity is plotted against different rebinding thresholds for the most potent group of peptides (A) and the second most potent group of peptides (B). The optimal thresholds are 60,000/M·s (A) and 45,000/ M·s (B). Fig. S6 . Sensitivity of receptor occupancy to parameter estimates. The predicted receptor occupancy for each pMHC-TCR pair is plotted, according to Eq. 1, using a K* of 130 μM as estimated in the main text (A) and with a K* three times stronger (43 μM) (B) and three times weaker (390 μM) (C). The different K*s model uncertainty in the concentration of TCRs on the surface of the cell and the conversion between SPR-measured affinities and affinities on the membrane. Fig. S7 . Sensitivity of rebinding to parameter estimates. Correlations between peptide potency and the t a are plotted with a rebinding threshold, k on *, of 60,000/M·s (A), as estimated in the main text, and with rebinding thresholds three times lower (20,000/M·s) (B) and three times higher (180,000/M·s) (C). The t a s were determined according to Eq. 2. The different rebinding thresholds model uncertainty in the diffusivities of the pMHCs and TCRs and the conversion between SPR-measured k on and k on on the membrane. Fig. S8 . Models are compared according to their ability to account for peptides with equal activity but different affinities, k on , and t 1/2 s. (A) Models are fit to the most potent group of peptides, which all have similar potency. The vertical, horizontal, and diagonal lines correspond to best-fits for the t 1/2 , affinity, and rebinding models, respectively. (B) Models are fit to the second most potent group of peptides. The best-fits for the rebinding model correspond to rebinding thresholds, k Ã on , of 32,000/M·s (A) and 45,000/M·s (B). These are similar to the best-fits obtained using the techniques in Fig. S5 .
